# 12-051/3 (2012-05-08)

Claudine de Meijer, Erasmus University Rotterdam; Marc Koopmanschap, Erasmus University Rotterdam; Owen O'Donnell, Erasmus University Rotterdam; Eddy van Doorslaer, Erasmus University Rotterdam
Health care expenditure, decomposition, aging, pharmaceuticals, the Netherlands
JEL codes:

This discussion paper resulted in an article in the Journal of Health Economics (2013). Volume 32, pages 88-105.

Explanations of growth in health expenditures have restricted attention to the mean. We explain change throughout the distribution of expenditures, providing insight into how growth and its explanation differ along the distribution. We analyse Dutch data on actual health expenditures linked to hospital discharge and mortality registers. Full distribution decomposition delivers findings that would be overlooked by examination of changes in the mean alone. The growth in expenditures on hospital care is strongest at the middle of the distribution and is driven mainly by changes in the distributions of determinants. Pharmaceutical expenditures increase most at the top of the distribution and are mainly attributable to structural changes, including technological progress, making treatment of the highest cost cases even more expensive. Changes in hospital practice styles make the largest contribution of all determinants to increased spending not only on hospital care but also on pharmaceuticals, suggesting important spill over effects.